NYSE · FMC

FMC Corporation

$11.30 -$0.39 (-3.34%) 1D After hours
Charting by TradingView

Key Metrics

$1.46B
Market cap
—
P/E · TTM
$3.43B
Revenue · TTM
−$2.50B
Net income
EPS · TTM $-20.02
Dividend yield 15.6%
Free cash flow −$143.40M
Beta · 1Y 1.10
EBITDA · TTM −$1.87B
Gross margin 35.3%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jul 14
    From its Apr 13 high, the share price fell 41%.

    Peak close $18.07 on Apr 13; trough close $10.72 on Jul 14. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -41%
  • Feb 12
    The stock moved -9.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 12
  • Feb 5
    The stock moved -19.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 5

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$1.46B
Enterprise value$4.43B
Shares outstanding125.2M
52-wk range$10.56 – $43.07
Avg volume · 20D1.8M
Net cash −$2.97B
Book value / share$14.57
IndustryChemicals & Allied Products
ExchangeNYSE
About FMC Corporation
IPO dateMay 29, 1986
Employees5500

FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E—
P/S0.43
P/FCF—
EV/EBITDA—
EV/Sales1.29
Graham №—

Profitability

Gross 35.3%
Operating -59.4%
Net -72.9%
FCF -4.2%
ROE / ROIC -79.4% · -51.2%

Financial Health

Current ratio1.29
Quick ratio0.96
Debt / equity1.84
Debt / EBITDA -1.80
Net cash −$2.97B
Working capital$1.09B

Cash Flow · TTM

Operating CF −$62.10M
Capex −$81.30M
Free cash flow −$143.40M
Buybacks —
Dividends paid $228.60M
Shareholder yield 15.6%

Piotroski F-Score

1 / 9
Weak fundamentals · 1 of 9 signals passing

Altman Z-Score

—
Insufficient balance-sheet inputs

Graham Number vs Price

—
Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings